These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 32977930)

  • 21. Factors affecting demand among older adults for medication therapy management services.
    Brooks JM; Unni EJ; Klepser DG; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2008 Dec; 4(4):309-19. PubMed ID: 19064238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors affecting Medicare Part D beneficiaries' decision to receive comprehensive medication reviews.
    Doucette WR; Zhang Y; Chrischilles EA; Pendergast JF; Newland BA; Farris KB; Frank J
    J Am Pharm Assoc (2003); 2013; 53(5):482-7. PubMed ID: 24030125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing Medicare Beneficiary Eligibility for Medication Therapy Management Programs Using PINNACLE, a National Cardiovascular Data Registry.
    Spinler SA; Cziraky MJ; Tang F; Dueñas GG; Thomas T; Reinhold JA; Willey VJ
    Am Health Drug Benefits; 2013 Sep; 6(7):367-74. PubMed ID: 24991369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perceptions of patients on Medicare Part D medication therapy management services.
    Truong HA; Layson-Wolf C; de Bittner MR; Owen JA; Haupt S
    J Am Pharm Assoc (2003); 2009; 49(3):392-8. PubMed ID: 19443319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A medication therapy management program's impact on low-density lipoprotein cholesterol goal attainment in Medicare Part D patients with diabetes.
    Fox D; Ried LD; Klein GE; Myers W; Foli K
    J Am Pharm Assoc (2003); 2009; 49(2):192-9. PubMed ID: 19289345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attitudes toward and factors affecting implementation of medication therapy management services by community pharmacists.
    MacIntosh C; Weiser C; Wassimi A; Reddick J; Scovis N; Guy M; Boesen K
    J Am Pharm Assoc (2003); 2009; 49(1):26-30. PubMed ID: 19196593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of a Medicare MTM program: evaluating clinical and economic outcomes.
    Hui RL; Yamada BD; Spence MM; Jeong EW; Chan J
    Am J Manag Care; 2014 Feb; 20(2):e43-51. PubMed ID: 24738554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Best practices: improving patient outcomes and costs in an ACO through comprehensive medication therapy management.
    Brummel A; Lustig A; Westrich K; Evans MA; Plank GS; Penso J; Dubois RW
    J Manag Care Spec Pharm; 2014 Dec; 20(12):1152-8. PubMed ID: 25597053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of telephonic comprehensive medication reviews on patient outcomes.
    DeZeeuw EA; Coleman AM; Nahata MC
    Am J Manag Care; 2018 Feb; 24(2):e54-e58. PubMed ID: 29461851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trends in Medicare Part D Medication Therapy Management Eligibility Criteria.
    Wang J; Shih YC; Qin Y; Young T; Thomas Z; Spivey CA; Solomon DK; Chisholm-Burns M
    Am Health Drug Benefits; 2015; 8(5):247-55. PubMed ID: 26380030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Best Practices: Improving Patient Outcomes and Costs in an ACO Through Comprehensive Medication Therapy Management.
    Brummel A; Lustig A; Westrich K; Evans MA; Plank GS; Penso J; Dubois RW
    J Manag Care Spec Pharm; 2014 Dec; 20(12):1152-8. PubMed ID: 25491911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of medicare part d on disparity implications of medication therapy management eligibility criteria.
    Wang J; Qiao Y; Shih YC; Jamison JJ; Spivey CA; Li L; Wan JY; White-Means SI; Dagogo-Jack S; Cushman WC; Chisholm-Burns M
    Am Health Drug Benefits; 2014 Sep; 7(6):346-58. PubMed ID: 25558303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacists' acceptable levels of compensation for MTM services: a conjoint analysis.
    Wang J; Hong SH; Meng S; Brown LM
    Res Social Adm Pharm; 2011 Dec; 7(4):383-95. PubMed ID: 21272533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Social determinants predict whether Medicare beneficiaries are offered a Comprehensive Medication Review.
    Lee M; Zarowitz BJ; Pellegrin K; Cooke CE; Fleming SP; Brandt N
    Res Social Adm Pharm; 2023 Jan; 19(1):184-188. PubMed ID: 36216754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medication therapy management and adherence among US renal transplant recipients.
    Chisholm-Burns MA; Spivey CA; Tolley EA; Kaplan EK
    Patient Prefer Adherence; 2016; 10():703-9. PubMed ID: 27175070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conjoint analysis of patient preferences on Medicare medication therapy management.
    Hong SH; Liu J; Wang J; Brown L; White-Means S
    J Am Pharm Assoc (2003); 2011; 51(3):378-87. PubMed ID: 21555290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and initial assessment of the medication user self-evaluation (MUSE) tool.
    Doucette WR; Chang EH; Pendergast JF; Wright KB; Chrischilles EA; Farris KB
    Clin Ther; 2013 Mar; 35(3):344-50. PubMed ID: 23453405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new ballgame: comprehensive medication review.
    McSpadden C
    Consult Pharm; 2014 Feb; 29(2):76-8, 80-1, 83. PubMed ID: 24513418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medication therapy management survey of the prescription drug plans.
    Boyd ST; Boyd LC; Zillich AJ
    J Am Pharm Assoc (2003); 2006; 46(6):692-9. PubMed ID: 17176684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Centers for Medicare and Medicaid Services Support for Medication Therapy Management (Enhanced Medication Therapy Management): Testing Strategies for Improving Medication Use Among Beneficiaries Enrolled in Medicare Part D.
    Brandt NJ; Cooke CE
    Clin Geriatr Med; 2017 May; 33(2):153-164. PubMed ID: 28364988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.